Identification of New Inhibitors with Potential Antitumor Activity from Polypeptide Structures via Hierarchical Virtual Screening

Autor: Luciane B. Silva, André L S Ferreira, Carlos Henrique Tomich de Paula da Silva, Mayara Amoras Teles Fujishima, Glauber V da Costa, Leonardo B Federico, Cleydson B. R. Santos, Williams Jorge da Cruz Macêdo, Elenilze F B Ferreira, Joaquín María Campos Rosa, Rozires P Leão, Josivan da Silva Costa
Rok vydání: 2019
Předmět:
Zdroj: Molecules
Volume 24
Issue 16
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Digibug. Repositorio Institucional de la Universidad de Granada
instname
Molecules, Vol 24, Iss 16, p 2943 (2019)
ISSN: 1420-3049
DOI: 10.3390/molecules24162943
Popis: Leukemias are neoplasms that affect hematopoietic cells, which are developed by genetic alterations (mutations) that lead to the loss of proliferation control mechanisms (maturation and/or cell death). The &alpha
4&beta
1 integrin receptor is a therapeutic target for inflammation, autoimmune diseases and lymphoid tumors. This study was carried out to search through the antagonists-based virtual screening for &alpha
1 receptor. Initially, seventeen (17) structures were selected (based on the inhibitory activity values, IC50) and the structure with the best value was chosen as the pivot. The pharmacophoric pattern was determined from the online PharmaGist server and resulted in a model of score value equal to 97.940 with 15 pharmacophoric characteristics that were statistically evaluated via Pearson correlations, principal component analysis (PCA) and hierarchical clustering analysis (HCA). A refined model generated four pharmacophoric hypotheses totaling 1.478 structures set of Zinc_database. After, the pharmacokinetic, toxicological and biological activity predictions were realized comparing with pivot structure that resulted in five (ZINC72088291, ZINC68842860, ZINC14365931, ZINC09588345 and ZINC91247798) structures with optimal in silico predictions. Therefore, future studies are needed to confirm antitumor potential activity of molecules selected this work with in vitro and in vivo assays.
Databáze: OpenAIRE
Nepřihlášeným uživatelům se plný text nezobrazuje